Home › Type 2 Diabetes › Oklahoma › Oklahoma City
Pag-aaral pangklinika para sa Type 2 Diabetes sa Oklahoma City, OK
Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Oklahoma City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Nagre-recruitPhase 3
- Tekton Research Oklahoma City, Oklahoma City
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Hightower Clinical, Oklahoma City
- Medical Research International, LLC, Oklahoma City
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Oklahoma City
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Nagre-recruitPhase 2
- Unity Clinical Research, Oklahoma City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
- Lynn Health Science Institute, Oklahoma City
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Oklahoma City
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Nagre-recruitPhase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Nagre-recruitObservasyonal na pag-aaral
- The University of Oklahoma Health Sciences Center, Oklahoma City
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Nagre-recruitPhase 2
- Lynn Health Science Institute - Oklahoma City, Oklahoma City
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL24 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL19 pag-aaral
- Chicago, IL19 pag-aaral
- Dallas, TX19 pag-aaral
- Columbus, OH18 pag-aaral
- Las Vegas, NV18 pag-aaral
- Atlanta, GA17 pag-aaral
- San Diego, CA17 pag-aaral
- Los Angeles, CA16 pag-aaral
Iba pang pag-aaral sa Oklahoma City
- Non-Small Cell Lung Cancer28 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Colorectal Cancer22 pag-aaral
- Kanser sa Prostate21 pag-aaral
- Kanser sa Baga19 pag-aaral
- Kanser sa Suso17 pag-aaral
- Metastatic Cancer15 pag-aaral
- Kanser (lahat ng uri)14 pag-aaral
- Acute Myeloid Leukemia14 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Kanser sa Pancreas11 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.